Rhumbline Advisers Purchases 2,918 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Rhumbline Advisers grew its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 4.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 75,581 shares of the company’s stock after acquiring an additional 2,918 shares during the period. Rhumbline Advisers’ holdings in Aveanna Healthcare were worth $410,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of AVAH. Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare in the first quarter worth about $25,000. BNP Paribas Financial Markets bought a new position in shares of Aveanna Healthcare in the fourth quarter worth about $35,000. Jump Financial LLC bought a new position in shares of Aveanna Healthcare in the first quarter worth about $59,000. ProShare Advisors LLC bought a new position in shares of Aveanna Healthcare in the fourth quarter worth about $67,000. Finally, Public Employees Retirement System of Ohio bought a new position in shares of Aveanna Healthcare in the fourth quarter worth about $121,000. 87.96% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on AVAH. Barclays raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Jefferies Financial Group raised shares of Aveanna Healthcare from a “hold” rating to a “buy” rating and dropped their price target for the stock from $6.25 to $6.00 in a research note on Monday, July 21st. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their price target for the stock from $6.00 to $10.00 in a research note on Thursday, September 18th. Truist Financial dropped their price target on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Finally, UBS Group raised shares of Aveanna Healthcare from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $6.75 to $8.00 in a research note on Tuesday, August 19th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $7.92.

Aveanna Healthcare Stock Down 0.4%

Shares of AVAH stock opened at $8.36 on Thursday. The firm has a fifty day moving average of $6.61 and a 200-day moving average of $5.54. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $8.68. The company has a market capitalization of $1.75 billion, a price-to-earnings ratio of 104.50 and a beta of 2.04.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.